<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T16:05:42Z</responseDate>
  <request identifier="oai:figshare.com:article/34017703" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34017703</identifier>
        <datestamp>2026-09-28T17:53:02Z</datestamp>
        <setSpec>category_915</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_8</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_128</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Example of one protein (MSP5, PVP01_0418400) with extensive inter-individual variations in antibody binding among patients.&lt;/p&gt;</dc:title>
          <dc:creator>Rosita Asawa (25132843)</dc:creator>
          <dc:creator>Brittany Hazzard (14271698)</dc:creator>
          <dc:creator>Katie Ko (12809883)</dc:creator>
          <dc:creator>Kieran Tebben (14504872)</dc:creator>
          <dc:creator>John Tan (1865173)</dc:creator>
          <dc:creator>Tineke Cantaert (68002)</dc:creator>
          <dc:creator>Andrea Berry (6244949)</dc:creator>
          <dc:creator>Niraj Tolia (25132846)</dc:creator>
          <dc:creator>Jean Popovici (423629)</dc:creator>
          <dc:creator>David Serre (2815)</dc:creator>
          <dc:subject>Physical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Microbiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Hematology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>select vaccine candidates</dc:subject>
          <dc:subject>host immune system</dc:subject>
          <dc:subject>entire protein sequences</dc:subject>
          <dc:subject>develop new tools</dc:subject>
          <dc:subject>density peptide array</dc:subject>
          <dc:subject>analyses also revealed</dc:subject>
          <dc:subject>5 billion people</dc:subject>
          <dc:subject>analyzed antibody responses</dc:subject>
          <dc:subject>many uncharacterized proteins</dc:subject>
          <dc:subject>plasmodium vivax &lt;/</dc:subject>
          <dc:subject>clinical vivax malaria</dc:subject>
          <dc:subject>plasmodium &lt;/</dc:subject>
          <dc:subject>vivax &lt;/</dc:subject>
          <dc:subject>clinical importance</dc:subject>
          <dc:subject>antibody response</dc:subject>
          <dc:subject>wide perspective</dc:subject>
          <dc:subject>wide characterization</dc:subject>
          <dc:subject>unique pattern</dc:subject>
          <dc:subject>symptomatic individuals</dc:subject>
          <dc:subject>stage infections</dc:subject>
          <dc:subject>several nucleoporins</dc:subject>
          <dc:subject>naïve individuals</dc:subject>
          <dc:subject>malaria community</dc:subject>
          <dc:subject>infection worldwide</dc:subject>
          <dc:subject>important resource</dc:subject>
          <dc:subject>erythrocyte invasion</dc:subject>
          <dc:subject>data provide</dc:subject>
          <dc:subject>better detecting</dc:subject>
          <dc:subject>asymptomatic individuals</dc:subject>
          <dc:subject>antigens using</dc:subject>
          <dc:description>&lt;p&gt;The x-axis represents the position of consecutive peptides assessed by the high-density array and the y-axis the fluorescence measured at each peptide. The yellow, orange and brown lines show the IgG antibody binding for three Cambodian patients, while the blue lines represent data from all malaria-naïve individuals (n = 10). The horizontal lines under the plot show locations where seven or more consecutive peptides have a signal greater than all malaria-naïve controls (colored by patient). The blue and orange boxes under each plot indicate annotated functional regions.&lt;/p&gt; &lt;p&gt;(TIF)&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T17:53:52Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.ppat.1014621.s003</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_Example_of_one_protein_MSP5_PVP01_0418400_with_extensive_inter-individual_variations_in_antibody_binding_among_patients_p_/34017703</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
